{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:52:45Z","timestamp":1754146365334,"version":"3.41.2"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Autoimmune Lymphoproliferative Syndrome (ALPS) is a rare immunological disorder caused by defective apoptosis, commonly due to pathogenic variants in the <jats:italic>FAS<\/jats:italic> gene. We report a comprehensive clinical, immunophenotypic, molecular, and functional evaluation of nine members of a consanguineous Brazilian family harboring the pathogenic <jats:italic>FAS<\/jats:italic> (NM_000043.6:c.748C\u2009&amp;gt;\u2009T) variant. The index case, an 11-year-old boy, presented with recurrent cytopenias, splenomegaly, and increased double-negative T cells. Genetic analysis identified additional variants in <jats:italic>CASP10<\/jats:italic> (NM_032977.4:c.1202_1208del), and <jats:italic>LRBA<\/jats:italic> (NM_001364905.1:c.2450-7C\u2009&amp;gt;\u2009T), evidencing a complex genotype. Functional assays confirmed different levels of impaired FAS-mediated apoptosis in some affected individuals. Among nine family members studied, four out them met clinical and molecular criteria for ALPS, demonstrating incomplete penetrance and variable phenotype. All affected individuals share the same variants in <jats:italic>FAS<\/jats:italic> and <jats:italic>CASP10<\/jats:italic>, yet their clinical presentations differ significantly. Clinical manifestations and elevated double-negative T cells were observed exclusively in male individuals. Notably, a female family member harboring both <jats:italic>FAS<\/jats:italic> and <jats:italic>CASP10<\/jats:italic> variants remained asymptomatic, supporting previous findings of incomplete penetrance and suggesting that sex-related factors\u2014possibly including hormonal influences\u2014may modulate clinical expression in ALPS. Introduction of sirolimus therapy led to sustained remission in the index case. This study report a successful integration of multimodal diagnostic strategy for accurate identification and management of ALPS, and it highlights the potential role of targeted therapies in improving outcomes.<\/jats:p>","DOI":"10.3389\/fped.2025.1639749","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T05:23:59Z","timestamp":1752816239000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Clinical, molecular, and functional characterization of autoimmune lymphoproliferative syndrome\u2014a family study with a multimodal diagnosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Bruna C\u00e2ndido","family":"Guido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroliny Victoria dos Santos","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Carolina Silva","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob\u00e9ria Mendon\u00e7a","family":"de Pontes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agenor de Castro Moreira dos","family":"Santos J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel Alves","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fab\u00edola Scancetti","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre de Albuquerque","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina Mescouto","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1182\/hematology.2024000537","article-title":"Beyond FAScinating: advances in diagnosis and management of autoimmune lymphoproliferative syndrome and activated PI3 kinase \u03b4 syndrome","volume":"2024","author":"Rao","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10875-024-01772-z","article-title":"Genetic testing in patients with autoimmune lymphoproliferative syndrome: experience of 802 patients at cincinnati children\u2019s hospital medical center","volume":"44","author":"Xu","year":"2024","journal-title":"J Clin Immunol"},{"key":"B3","author":"Bleesing","year":"2023"},{"key":"B4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00277-022-04761-7","article-title":"ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies","volume":"101","author":"Consonni","year":"2022","journal-title":"Ann Hematol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jaci.2023.09.028","article-title":"Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome","volume":"153","author":"Pell\u00e9","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1182\/blood-2012-12-469544","article-title":"Loss-of-function of the protein kinase C \u03b4 (PKC\u03b4) causes a B-cell lymphoproliferative syndrome in humans","volume":"121","author":"Kuehn","year":"2013","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"656356","DOI":"10.3389\/fimmu.2021.656356","article-title":"Next generation sequencing for detecting somatic fas mutations in patients with autoimmune lymphoproliferative syndrome","volume":"12","author":"L\u00f3pez-Nevado","year":"2021","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/pai.13535","article-title":"Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: a systematic review","volume":"32","author":"Hafezi","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s10875-018-0523-x","article-title":"The autoimmune lymphoproliferative syndrome with defective FAS or FAS-ligand functions","volume":"38","author":"Rieux-Laucat","year":"2018","journal-title":"J Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41419-024-06679-6","article-title":"Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome","volume":"15","author":"Consonni","year":"2024","journal-title":"Cell Death Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/bjh.16098","article-title":"FAS-mediated apoptosis impairment in patients with ALPS\/ALPS-like phenotype carrying variants on CASP10 gene","volume":"187","author":"Miano","year":"2019","journal-title":"Br J Haematol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s00439-006-0138-9","article-title":"Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome","volume":"119","author":"Zhu","year":"2006","journal-title":"Hum Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.3390\/ijms23105366","article-title":"Differential expression of proteins in an atypical presentation of autoimmune lymphoproliferative syndrome","volume":"23","author":"Delgadillo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e845","DOI":"10.1097\/HS9.0000000000000845","article-title":"Autoimmune lymphoproliferative syndrome (ALPS) disease and ALPS phenotype: are they two distinct entities?","volume":"7","author":"Palmisani","year":"2023","journal-title":"Hemasphere"},{"key":"B15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.29262\/ram.v66i4.646","article-title":"Autoimmune lymphoproliferative syndrome. Update and review","volume":"66","author":"Su\u00e1rez-Guti\u00e9rrez","year":"2019","journal-title":"Rev Alerg Mex"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.12688\/f1000research.11545.1","article-title":"Autoimmune lymphoproliferative syndrome: more than a FAScinating disease","volume":"6","author":"Bride","year":"2017","journal-title":"F1000Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"868193","DOI":"10.3389\/fped.2022.868193","article-title":"Case report: effectiveness of sirolimus in a de novoFAS mutation leading to autoimmune lymphoproliferative syndrome-FAS and elevated DNT\/treg ratio","volume":"10","author":"Gu","year":"2022","journal-title":"Front Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/21678707.2021.1970523","article-title":"Efficacy of sirolimus for treatment of autoimmune lymphoproliferative syndrome: a systematic review of open label clinical studies","volume":"9","author":"Sharma","year":"2021","journal-title":"Expert Opin Orphan Drugs"},{"key":"B19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0092-8674(00)80605-4","article-title":"Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II","volume":"98","author":"Wang","year":"1999","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature01063","article-title":"Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency","volume":"419","author":"Chun","year":"2002","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","article-title":"A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation","volume":"118","author":"Neven","year":"2011","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"eadj5948","DOI":"10.1126\/sciimmunol.adj5948","article-title":"Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells","volume":"9","author":"Staniek","year":"2024","journal-title":"Sci Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s00467-003-1087-3","article-title":"Autoimmune lymphoproliferative syndrome presenting with glomerulonephritis","volume":"18","author":"Kanegane","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5858\/arpa.2018-0190-RS","article-title":"Autoimmune lymphoproliferative syndrome: an overview","volume":"144","author":"Matson","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1182\/blood-2011-07-325217","article-title":"How I treat autoimmune lymphoproliferative syndrome","volume":"118","author":"Rao","year":"2011","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s10875-014-0038-z","article-title":"Elevated double negative T cells in pediatric autoimmunity","volume":"34","author":"Tarbox","year":"2014","journal-title":"J Clin Immunol"},{"key":"B27","article-title":"GeneReviews","author":"Adam","year":"1993"},{"key":"B28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/gim.0b013e3182310b7d","article-title":"Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance","volume":"14","author":"Hsu","year":"2012","journal-title":"Genet Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1086\/302333","article-title":"Autoimmune lymphoproliferative syndrome with defective fas: genotype influences penetrance","volume":"64","author":"Jackson","year":"1999","journal-title":"Am J Hum Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"103442","DOI":"10.1016\/j.autrev.2023.103442","article-title":"Autoimmune lymphoproliferative syndrome: a disorder of immune dysregulation","volume":"22","author":"Paskiewicz","year":"2023","journal-title":"Autoimmun Rev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0140-6736(96)02293-3","article-title":"Clinical, immunological, and pathological consequences of fas-deficient conditions","volume":"348","author":"Le Deist","year":"1996","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to Abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.25100\/cm.v49i3.3802","article-title":"LRBA in the endomembrane system","volume":"49","author":"Mart\u00ednez Jaramillo","year":"2018","journal-title":"Colomb Med (Cali)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/10428190310001593166","article-title":"Development of lymphoma in autoimmune lymphoproliferative syndrome (ALPS) and its relationship to fas gene mutations","volume":"45","author":"Poppema","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"B35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1182\/blood.V98.1.194","article-title":"The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline fas mutations and defective lymphocyte apoptosis","volume":"98","author":"Straus","year":"2001","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.7326\/0003-4819-130-7-199904060-00020","article-title":"An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome","volume":"130","author":"Straus","year":"1999","journal-title":"Ann Intern Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1639749\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T05:24:00Z","timestamp":1752816240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1639749\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":36,"alternative-id":["10.3389\/fped.2025.1639749"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1639749","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"article-number":"1639749"}}